RPID
Rapid Micro Biosystems Inc
NASDAQ: RPID · HEALTHCARE · MEDICAL DEVICES
$2.30
-6.50% today
Updated 2026-04-29
Market cap
$112.59M
P/E ratio
—
P/S ratio
3.35x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.5
Quality
C+2.0
Profitability
F4.0
Valuation
C3/9
Piotroski F-Score
Weak
-5.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$8.00
+247.83%
12-Month target
—
—
Intrinsic (DCF)
$3.49
Margin of safety
-20.34%
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 37.30% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -5.27 — distress zone
- Thin margins at -140.30%
- Negative free cash flow $-2.46M
- 20.34% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $17.13M | $22.52M | $28.05M | $33.59M | $33.59M |
| Net income | $-60.81M | $-52.47M | $-46.89M | $-47.12M | $-12.50M |
| EPS | — | — | — | — | $-1.00 |
| Free cash flow | $-65.29M | $-46.93M | $-45.52M | $-31.91M | $-2.46M |
| Profit margin | -354.91% | -232.99% | -167.16% | -140.30% | -140.30% |
Peer comparison
Smart narrative
Rapid Micro Biosystems Inc trades at $2.30. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -5.27, it sits in the distress. TTM revenue stands at $33.59M. with profit margins at -140.30%. Our DCF model estimates intrinsic value at $3.49.
Frequently asked questions
What is Rapid Micro Biosystems Inc's stock price?
Rapid Micro Biosystems Inc (RPID) trades at $2.30.
Is Rapid Micro Biosystems Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $3.49.
What is the price target of Rapid Micro Biosystems Inc (RPID)?
The analyst target price is $8.00, representing +247.8% upside from the current price of $2.30.
What is the intrinsic value of Rapid Micro Biosystems Inc (RPID)?
Based on our DCF model, intrinsic value is $3.49, a -20.3% margin of safety versus $2.30.
What is Rapid Micro Biosystems Inc's revenue?
TTM revenue is $33.59M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-5.27 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.35x
ROE-86.80%
Beta1.60
50D MA$3.00
200D MA$3.32
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—